Bio Green Med Solution, Inc.
$1.19
▲
1.13%
2026-04-21 05:38:01
bgmsglobal.com
NCM: BGMS
Explore Bio Green Med Solution, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.54 M
Current Price
$1.19
52W High / Low
$100.8 / $0.73
Stock P/E
—
Book Value
$1.27
Dividend Yield
0.93%
ROCE
552.16%
ROE
-1.28%
Face Value
—
EPS
$-6.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
—
Beta
-0.53
Debt / Equity
0.03
Current Ratio
4.7
Quick Ratio
3.66
Forward P/E
—
Price / Sales
7.45
Enterprise Value
$2.06 M
EV / EBITDA
-0.24
EV / Revenue
2.76
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Precision BioSciences, Inc. | $7.58 | — | $187.43 M | — | -35.84% | -62.71% | $8.82 / $3.53 | $3.83 |
| 2. | Gain Therapeutics, Inc. | $2.12 | — | $89.98 M | — | -96.12% | -1.56% | $4.34 / $1.41 | $0.44 |
| 3. | Context Therapeutics Inc. | $2.26 | — | $223.27 M | — | -65.65% | -46.39% | $3.62 / $0.49 | $0.66 |
| 4. | EyePoint, Inc. | $15.07 | — | $1.26 B | — | -74.45% | -72.19% | $19.11 / $5.3 | $3.7 |
| 5. | Dianthus Therapeutics, Inc. | $91.92 | — | $5 B | — | -35.57% | -38.38% | $96.5 / $16.64 | $11.41 |
| 6. | Kymera Therapeutics, Inc. | $88.84 | — | $7.31 B | — | -20.82% | -25.78% | $103 / $24.43 | $19.42 |
| 7. | TScan Therapeutics, Inc. | $1.43 | — | $67.71 M | — | -64.64% | -71.28% | $2.57 / $0.88 | $2.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.67 M | 0.08 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -1.08 M | -0.99 M | -1.32 M | -5.04 M | -1.83 M | — |
| Net Profit | -0.61 M | -0.99 M | -1.32 M | -0.08 M | -3.05 M | — |
| EPS in Rs | -0.11 | -0.18 | -0.24 | -0.01 | -0.55 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.75 M | 0.04 M | 0.42 M | 0 M |
| Operating Profit | -8.43 M | -12 M | -25.45 M | -27.66 M |
| Net Profit | -3 M | -11.21 M | -22.55 M | -21.2 M |
| EPS in Rs | -0.54 | -2.03 | -4.09 | -3.84 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 8.19 M | 4.09 M | 8.8 M | 28.05 M |
| Total Liabilities | 1.34 M | 6.27 M | 8.2 M | 7.62 M |
| Equity | 6.84 M | -2.17 M | 0.61 M | 20.43 M |
| Current Assets | 6.26 M | 3.67 M | 7.44 M | 24.41 M |
| Current Liabilities | 1.33 M | 6.27 M | 8.16 M | 7.51 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.77 M | -7.99 M | -16.11 M | -20.83 M |
| Investing CF | 0 M | 0 M | -0.01 M | -0.01 M |
| Financing CF | 5.26 M | 7.82 M | 0.85 M | 3 M |
| Free CF | -4.77 M | -7.99 M | -16.12 M | -20.83 M |
| Capex | — | — | -0.01 M | -0.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -89.76% | — | — | — |
| Earnings Growth % | 50.29% | -6.4% | — | — |
| Profit Margin % | -26074.42% | -5370.24% | — | — |
| Operating Margin % | -27916.28% | -6060.24% | — | — |
| Gross Margin % | 100% | — | — | — |
| EBITDA Margin % | -27902.33% | -6052.86% | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-04-29 | $36 |
Stock Splits
| Date | Split |
|---|---|
| 2025-07-07 | 1:0.0666667 |
| 2025-05-12 | 1:0.0625 |
| 2023-12-18 | 1:0.0666667 |